New Research for Parkinson’s Disease

June 24, 2019

At Re:Cognition Health, our team are passionate about early accurate diagnosis and intervention to optimise health and treatment plans for Parkinson’s disease.

We are very enthused by the latest research undertaken by scientists at King’s College London which has indicated that early signs of Parkinson’s disease develop in the brain many years before symptoms appear.

The study suggests that changes in the serotonin system comes before damage to the dopamine symptom occurs and before movement is affected.

Measuring serotonin levels could be the key to detect Parkinson’s in individuals at risk.

Whilst further work needs to be undertaken to fully understand the impact of this study, the research is extremely encouraging and will pave the way for better understanding, diagnosis and treatment for Parkinson’s disease.

Dr Emer MacSweeney, CEO and Consultant Neuroradiologist at Re:Cognition Health gave her expert advice to Yahoo! News regarding the early symptoms of Parkinson’s disease. Dr MacSweeney comments, “Motor symptoms such as muscle rigidity, tremors, involuntary shaking and slowness of movement are all early signs of the disease and symptoms often start on one side of the body.”

Dr MacSweeney also explains other key signs can include problems with balance, a change in facial expressions, a softening of the voice and small handwriting. She also explains that mental health can be compromised for individuals with Parkinson’s disease and dementia is an increased risk associated with the disease.


To read the full article in Yahoo! Visit:


For further information on Parkinson’s Disease:

What is Parkinson’s Disease?


To find out more about clinical trials, at Re:Cognition Clinics, providing the opportunity, today, to access new generation treatments for Parkinson’s disease: please contact our team clinician@re-cognitionhealth.com

Help us make a difference in cognitive health

Sign Up Now